Quick takeaway: Researchers have not established BPC-157 as a reliable, direct weight-loss tool in humans
Proteomics 96:253-262(2014)
However, they should be disclosed during your pre-injection consultation so that you can plan accordingly especially if you are receiving an injection during a lunch break or before an important event
(PubMed) Flores-Mateo G, Carrillo-Santisteve P, Elosua R, et al
Jude Shared Resources and Core Facilities, including Animal Research Center, Transgenic/Gene Knockout, Proteomics and Metabolomics
Key Research Findings CAM Assay: BPC-157 increases blood vessel formation in chorioallantoic membrane models Wound Models: Enhanced angiogenesis observed in cutaneous wound healing studies VEGF Blockade: VEGF inhibitors (bevacizumab) partially block BPC-157's healing effects, confirming VEGF involvement L-NAME Studies: NOS inhibition reduces BPC-157 efficacy, confirming NO pathway involvement Potential Applications The angiogenic mechanism suggests utility in: Chronic Wounds: Diabetic ulcers and pressure sores with impaired healing Sports Injuries: Tendon, ligament, and muscle repair Post-Surgical: Accelerating anastomotic and incisional healing Ischemic Conditions: Enhancing blood supply to poorly perfused tissues Considerations Cancer Context: Angiogenesis is a concern in malignancy